DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies

Abstract

The inducible co-stimulator (ICOS) is a member of the CD28/B7 superfamily, and delivers a positive co-stimulatory signal to activated T cells upon binding to its ligand (ICOS-L). Dysregulation of this pathway has been implicated in autoimmune diseases and cancer, and is currently under clinical investigation as an immune checkpoint blockade. Here, we describe the molecular interactions of the ICOS/ICOS-L immune complex at 3.3 Å resolution. A central FDPPPF motif and residues within the CC’ loop of ICOS are responsible for the specificity of the interaction with ICOS-L, with a distinct receptor binding orientation in comparison to other family members. Furthermore, our structure and binding data reveal that the ICOS N110 N-linked glycan participates in ICOS-L binding. In addition, we report crystal structures of ICOS and ICOS-L in complex with monoclonal antibodies under clinical evaluation in immunotherapy. Strikingly, antibody paratopes closely mimic receptor-ligand binding core interactions, in addition to contacting peripheral residues to confer high binding affinities. Our results uncover key molecular interactions of an immune complex central to human adaptive immunity and have direct implications for the ongoing development of therapeutic interventions targeting immune checkpoint receptors.

Authors:
 [1];  [2];  [3];  [2]; ORCiD logo [3]
  1. The Hospital for Sick Children Research Inst., Toronto, ON (Canada); Univ. of the Basque Country (UPV/EHU), Bilbao (Spain)
  2. The Hospital for Sick Children Research Inst., Toronto, ON (Canada)
  3. The Hospital for Sick Children Research Inst., Toronto, ON (Canada); Univ. of Toronto, ON (Canada)
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS); Brookhaven National Lab. (BNL), Upton, NY (United States). National Synchrotron Light Source II (NSLS-II)
Sponsoring Org.:
European Union (EU); Canadian Institutes of Health Research (CIHR); Canadian Institute for Advanced Research (CIFAR); Canada Research Chairs Program; National Cancer Institute (NCI); National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH); USDOE Office of Science (SC), Biological and Environmental Research (BER)
OSTI Identifier:
1682336
Grant/Contract Number:  
790012; PJT-148811; S10 OD012289; AC02-06CH11357; SC0012704; P41GM111244
Resource Type:
Accepted Manuscript
Journal Name:
Nature Communications
Additional Journal Information:
Journal Volume: 11; Journal Issue: 1; Journal ID: ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
ENGLISH
Subject:
60 APPLIED LIFE SCIENCES; Immunotherapy; X-ray crystallography

Citation Formats

Rujas, Edurne, Cui, Hong, Sicard, Taylor, Semesi, Anthony, and Julien, Jean-Philippe. Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies. United States: N. p., 2020. Web. doi:10.1038/s41467-020-18828-4.
Rujas, Edurne, Cui, Hong, Sicard, Taylor, Semesi, Anthony, & Julien, Jean-Philippe. Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies. United States. https://doi.org/10.1038/s41467-020-18828-4
Rujas, Edurne, Cui, Hong, Sicard, Taylor, Semesi, Anthony, and Julien, Jean-Philippe. Thu . "Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies". United States. https://doi.org/10.1038/s41467-020-18828-4. https://www.osti.gov/servlets/purl/1682336.
@article{osti_1682336,
title = {Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies},
author = {Rujas, Edurne and Cui, Hong and Sicard, Taylor and Semesi, Anthony and Julien, Jean-Philippe},
abstractNote = {The inducible co-stimulator (ICOS) is a member of the CD28/B7 superfamily, and delivers a positive co-stimulatory signal to activated T cells upon binding to its ligand (ICOS-L). Dysregulation of this pathway has been implicated in autoimmune diseases and cancer, and is currently under clinical investigation as an immune checkpoint blockade. Here, we describe the molecular interactions of the ICOS/ICOS-L immune complex at 3.3 Å resolution. A central FDPPPF motif and residues within the CC’ loop of ICOS are responsible for the specificity of the interaction with ICOS-L, with a distinct receptor binding orientation in comparison to other family members. Furthermore, our structure and binding data reveal that the ICOS N110 N-linked glycan participates in ICOS-L binding. In addition, we report crystal structures of ICOS and ICOS-L in complex with monoclonal antibodies under clinical evaluation in immunotherapy. Strikingly, antibody paratopes closely mimic receptor-ligand binding core interactions, in addition to contacting peripheral residues to confer high binding affinities. Our results uncover key molecular interactions of an immune complex central to human adaptive immunity and have direct implications for the ongoing development of therapeutic interventions targeting immune checkpoint receptors.},
doi = {10.1038/s41467-020-18828-4},
journal = {Nature Communications},
number = 1,
volume = 11,
place = {United States},
year = {Thu Oct 08 00:00:00 EDT 2020},
month = {Thu Oct 08 00:00:00 EDT 2020}
}

Works referenced in this record:

The Interaction Properties of Costimulatory Molecules Revisited
journal, August 2002


Cemiplimab: First Global Approval
journal, November 2018


De novo design of potent and selective mimics of IL-2 and IL-15
journal, January 2019


Synthesis and Crystal Structure of the Copper Complex of 7,16-Bis(2-hydroxy-5-methylbenzyl)-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane
journal, January 2004

  • Ma, Shu-Lan; Zhu, Wen-Xiang; Guo, Qian-Ling
  • Chinese Journal of Chemistry, Vol. 22, Issue 1
  • DOI: 10.1002/cjoc.20040220114

Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses
journal, March 2001

  • Stamper, Carin C.; Zhang, Yan; Tobin, James F.
  • Nature, Vol. 410, Issue 6828
  • DOI: 10.1038/35069118

Structural basis for co-stimulation by the human CTLA-4/B7-2 complex
journal, March 2001

  • Schwartz, Jean-Claude D.; Zhang, Xuewu; Fedorov, Alexander A.
  • Nature, Vol. 410, Issue 6828
  • DOI: 10.1038/35069112

T Follicular Helper Cell Differentiation, Function, and Roles in Disease
journal, October 2014


Crystal Structure of a Shark Single-Domain Antibody V Region in Complex with Lysozyme
journal, September 2004


Collaboration gets the most out of software
journal, September 2013


ICOS is essential for effective T-helper-cell responses
journal, January 2001

  • Tafuri, Anna; Shahinian, Arda; Bladt, Friedhelm
  • Nature, Vol. 409, Issue 6816
  • DOI: 10.1038/35051113

Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
journal, July 2017


A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications
journal, January 2002

  • Nagai, Takeharu; Ibata, Keiji; Park, Eun Sun
  • Nature Biotechnology, Vol. 20, Issue 1
  • DOI: 10.1038/nbt0102-87

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
journal, April 2016


Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor
journal, February 2000


B7h, a Novel Costimulatory Homolog of B7.1 and B7.2, Is Induced by TNFα
journal, October 1999


Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions
journal, October 1996

  • Greene, JoAnne L.; Leytze, Gina M.; Emswiler, John
  • Journal of Biological Chemistry, Vol. 271, Issue 43
  • DOI: 10.1074/jbc.271.43.26762

A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1
journal, May 2016

  • Pedros, Christophe; Zhang, Yaoyang; Hu, Joyce K.
  • Nature Immunology, Vol. 17, Issue 7
  • DOI: 10.1038/ni.3463

Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation
journal, October 2003


The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system
journal, April 2006

  • Qian, Xuesong; Agematsu, Kazunaga; Freeman, Gordon J.
  • European Journal of Immunology, Vol. 36, Issue 4
  • DOI: 10.1002/eji.200535253

Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency
journal, February 2003

  • Grimbacher, Bodo; Hutloff, Andreas; Schlesier, Michael
  • Nature Immunology, Vol. 4, Issue 3
  • DOI: 10.1038/ni902

Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
journal, May 2013

  • Vigdorovich, Vladimir; Ramagopal, Udupi A.; Lázár-Molnár, Eszter
  • Structure, Vol. 21, Issue 5
  • DOI: 10.1016/j.str.2013.03.003

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
journal, August 2010

  • Hodi, F. Stephen; O'Day, Steven J.; McDermott, David F.
  • New England Journal of Medicine, Vol. 363, Issue 8
  • DOI: 10.1056/NEJMoa1003466

XDS
journal, January 2010

  • Kabsch, Wolfgang
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
  • DOI: 10.1107/S0907444909047337

Inference of Macromolecular Assemblies from Crystalline State
journal, September 2007


ICOS:ICOS-Ligand Interaction Is Required for Type 2 Innate Lymphoid Cell Function, Homeostasis, and Induction of Airway Hyperreactivity
journal, March 2015


ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
journal, January 1999

  • Hutloff, Andreas; Dittrich, Anna M.; Beier, Katja C.
  • Nature, Vol. 397, Issue 6716
  • DOI: 10.1038/16717

ICOS controls the pool size of effector-memory and regulatory T cells
journal, February 2008


Characterization of Human Inducible Costimulator Ligand Expression and Function
journal, May 2000

  • Aicher, Alexandra; Hayden-Ledbetter, Martha; Brady, William A.
  • The Journal of Immunology, Vol. 164, Issue 9
  • DOI: 10.4049/jimmunol.164.9.4689

Further study of anti-ICOS immunotherapy for rat cardiac allograft rejection
journal, August 2008


Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
journal, July 2010


Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4 + T Cells
journal, November 2000

  • McAdam, Alexander J.; Chang, Tammy T.; Lumelsky, Anna E.
  • The Journal of Immunology, Vol. 165, Issue 9
  • DOI: 10.4049/jimmunol.165.9.5035

Nonimmune cell–derived ICOS ligand functions as a renoprotective αvβ3 integrin–selective antagonist
journal, March 2019

  • Koh, Kwi Hye; Cao, Yanxia; Mangos, Steve
  • Journal of Clinical Investigation, Vol. 129, Issue 4
  • DOI: 10.1172/JCI123386

A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin
journal, February 2013

  • Xu, Rui; Krause, Jens C.; McBride, Ryan
  • Nature Structural & Molecular Biology, Vol. 20, Issue 3
  • DOI: 10.1038/nsmb.2500

Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility
journal, April 2013


Inducible T‐cell co‐stimulator: Signaling mechanisms in T follicular helper cells and beyond
journal, August 2019

  • Panneton, Vincent; Chang, Jinsam; Witalis, Mariko
  • Immunological Reviews, Vol. 291, Issue 1
  • DOI: 10.1111/imr.12771

Features and development of Coot
journal, March 2010

  • Emsley, P.; Lohkamp, B.; Scott, W. G.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
  • DOI: 10.1107/S0907444910007493

Ligand Binding Sites of Inducible Costimulator and High Avidity Mutants with Improved Function
journal, April 2002

  • Wang, Shengdian; Zhu, Gefeng; Tamada, Koji
  • Journal of Experimental Medicine, Vol. 195, Issue 8
  • DOI: 10.1084/jem.20011607

Inhibition of Chronic Rejection and Development of Tolerogenic T Cells after ICOS-ICOSL and CD40-CD40L Co-stimulation Blockade
journal, January 2005


T-cell co-stimulation through B7RP-1 and ICOS
journal, December 1999

  • Yoshinaga, Steven K.; Whoriskey, John S.; Khare, Sanjay D.
  • Nature, Vol. 402, Issue 6763
  • DOI: 10.1038/45582

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
journal, July 2015

  • Larkin, James; Chiarion-Sileni, Vanna; Gonzalez, Rene
  • New England Journal of Medicine, Vol. 373, Issue 1
  • DOI: 10.1056/NEJMoa1504030

PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)
journal, June 2010

  • Simpson, Tyler R.; Quezada, Sergio A.; Allison, James P.
  • Current Opinion in Immunology, Vol. 22, Issue 3
  • DOI: 10.1016/j.coi.2010.01.001

Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28
journal, July 1997

  • Metzler, William J.; Bajorath, Jürgen; Fenderson, William
  • Nature Structural Biology, Vol. 4, Issue 7
  • DOI: 10.1038/nsb0797-527

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
journal, March 2014

  • Fan, Xiaozhou; Quezada, Sergio A.; Sepulveda, Manuel A.
  • Journal of Experimental Medicine, Vol. 211, Issue 4
  • DOI: 10.1084/jem.20130590

Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
journal, February 2017

  • Zamarin, Dmitriy; Holmgaard, Rikke B.; Ricca, Jacob
  • Nature Communications, Vol. 8, Issue 1
  • DOI: 10.1038/ncomms14340

Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS
journal, October 2000

  • Yoshinaga, Steven K.; Zhang, Ming; Pistillo, Jeanne
  • International Immunology, Vol. 12, Issue 10
  • DOI: 10.1093/intimm/12.10.1439

ICOS is critical for CD40-mediated antibody class switching
journal, January 2001

  • McAdam, Alexander J.; Greenwald, Rebecca J.; Levin, Michele A.
  • Nature, Vol. 409, Issue 6816
  • DOI: 10.1038/35051107

A two-step, two-signal model for the primary activation of precursor helper T cells
journal, January 1999

  • Bretscher, P. A.
  • Proceedings of the National Academy of Sciences, Vol. 96, Issue 1
  • DOI: 10.1073/pnas.96.1.185

Crystal structure of a soluble CD28-Fab complex
journal, February 2005

  • Evans, Edward J.; Esnouf, Robert M.; Manso-Sancho, Raquel
  • Nature Immunology, Vol. 6, Issue 3
  • DOI: 10.1038/ni1170

Inducible costimulator (ICOS) potentiates TCR-induced calcium flux by augmenting PLCγ1 activation and actin remodeling
journal, November 2016


The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
journal, February 2008

  • Lin, D. Y. -w.; Tanaka, Y.; Iwasaki, M.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 8
  • DOI: 10.1073/pnas.0712278105

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
journal, February 2018


Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo.
journal, February 1987

  • Jenkins, M. K.; Schwartz, R. H.
  • Journal of Experimental Medicine, Vol. 165, Issue 2
  • DOI: 10.1084/jem.165.2.302

CCR5 Mimicry by Sulfated Human Anti-HIV-1 Antibodies
journal, July 2003


ICOS co-stimulatory receptor is essential for T-cell activation and function
journal, January 2001

  • Dong, Chen; Juedes, Amy E.; Temann, Ulla-Angela
  • Nature, Vol. 409, Issue 6816
  • DOI: 10.1038/35051100

Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase
journal, November 2009

  • Gigoux, M.; Shang, J.; Pak, Y.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 48
  • DOI: 10.1073/pnas.0911573106

Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206

Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments
journal, February 2018

  • Ereño-Orbea, June; Sicard, Taylor; Cui, Hong
  • Journal of Molecular Biology, Vol. 430, Issue 3
  • DOI: 10.1016/j.jmb.2017.12.010